PCM
ABBV icon

Park Capital Management’s AbbVie ABBV Stock Holding History

Park Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
1,046
+98
+10% +$21.1K 0.15% 102
2026
Q1 		$206K Sell
948
-28
-3% -$6.21K 0.2% 60
2025
Q4 		$223K Buy
976
+7
+0.7% +$1.59K 0.16% 76
2025
Q3 		$224K Buy
+969
New +$197K 0.18% 73

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Park Capital Management's ABBV Position: Q2 2026 in Review

Park Capital Management increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $21.1K and bringing the position to 1,046 shares worth $263K. The position accounts for 0.15% of the portfolio, ranked #102.

Park Capital Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Park Capital Management held 1,046 shares of AbbVie worth $263K as of Q2 2026.
  • Park Capital Management bought 98 AbbVie shares in Q2 2026, an estimated $21.1K.
  • AbbVie made up 0.15% of Park Capital Management's portfolio in Q2 2026, its #102 holding.
  • Park Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Park Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.